Literature DB >> 29668302

Clinical factors impacting on late dysphagia following radiotherapy in patients with head and neck cancer.

Sarah Deschuymer1, Daan Nevens1, Fréderic Duprez2, Annouschka Laenen3, Eddy Dejaeger4, Wilfried De Neve2, Ann Goeleven5,6, Sandra Nuyts1.   

Abstract

OBJECTIVE: Patient and treatment characteristics of patients with head and neck cancer (HNSCC) were correlated with dysphagia scored on swallowing-videofluoroscopy (VFS) and with patient- and physician-scored dysphagia.
METHODS: 63 HNSCC patients treated with radiotherapy (RT) were evaluated at baseline, and 6 and 12 months post-RT. VFS was scored with Penetration Aspiration Scale (PAS) and Swallowing Performance Scale (SPS). Physician- and patient-scored dysphagia were prospectively recorded according to Common Terminology Criteria for Adverse Events scoring system, Radiation Therapy Oncology Group/EORTC scoring system and European Organization for Research and Treatment of Cancer Quality of Life questionnaire (EORTC-QLQ H&N35).
RESULTS: Univariable analysis revealed a significant association between tumour-subsite and higher SPS (p = 0.02) and patient-scored dysphagia (p = 0.02) at baseline. At 12 months, tumour-subsite was significantly associated with higher PAS and SPS. Multivariable analysis and pairwise comparison showed that hypopharyngeal cancer and carcinoma of unknown primary  were associated with higher SPS at baseline and at 12 months, respectively (p = 0.03 and p = 0.01). Upfront neck dissection (UFND) was significantly associated with higher SPS and physician-scored dysphagia in univariable analysis at all timepoints. At 12 months, there was also a significant association with higher PAS (p < 0.01) and patient-scored dysphagia (p < 0.01). After multivariable analysis, the association between UFND and higher PAS (p < 0.01) and SPS (p < 0.01) remained significant at 12 months.
CONCLUSION: Hypopharyngeal tumours and carcinoma of unknown primary were related to more dysphagia at baseline and at 12 months, respectively. Furthermore, UFND was associated with more severe dysphagia scored by physicians and patients and on VFS at 12 months. Advances in knowledge: This is the first paper reporting a significant link between UFND and late dysphagia scored with VFS. We advocate abandoning UFND and preserving neck dissection as a salvage option post-RT.

Entities:  

Mesh:

Year:  2018        PMID: 29668302      PMCID: PMC6209460          DOI: 10.1259/bjr.20180155

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  40 in total

1.  CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

Authors:  Charlotte L Brouwer; Roel J H M Steenbakkers; Jean Bourhis; Wilfried Budach; Cai Grau; Vincent Grégoire; Marcel van Herk; Anne Lee; Philippe Maingon; Chris Nutting; Brian O'Sullivan; Sandro V Porceddu; David I Rosenthal; Nanna M Sijtsema; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2015-08-13       Impact factor: 6.280

2.  Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.

Authors:  Sandra Nuyts; Maarten Lambrecht; Fréderic Duprez; Jean-Francois Daisne; Dirk Van Gestel; Danielle Van den Weyngaert; Nele Platteaux; Yasmyne Geussens; Mia Voordeckers; Indira Madani; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2013-08-13       Impact factor: 6.280

3.  Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Authors:  M Lambrecht; D Nevens; S Nuyts
Journal:  Strahlenther Onkol       Date:  2013-01-16       Impact factor: 3.621

Review 4.  Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer.

Authors:  Fréderic Duprez; Indira Madani; Bruno De Potter; Tom Boterberg; Wilfried De Neve
Journal:  Dysphagia       Date:  2013-02-22       Impact factor: 3.438

5.  Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.

Authors:  Avraham Eisbruch; Hyungjin M Kim; Felix Y Feng; Teresa H Lyden; Marc J Haxer; Mary Feng; Frank P Worden; Carol R Bradford; Mark E Prince; Jeffrey S Moyer; Gregory T Wolf; Douglas B Chepeha; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-17       Impact factor: 7.038

6.  Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Authors:  Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

7.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Authors:  Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

Review 8.  Dysphagia in head and neck cancer patients treated with chemoradiotherapy.

Authors:  Nele Platteaux; Piet Dirix; Eddy Dejaeger; Sandra Nuyts
Journal:  Dysphagia       Date:  2009-08-27       Impact factor: 3.438

9.  Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation.

Authors:  Miriam N Lango; Brian Egleston; Kevin Ende; Steven Feigenberg; David J D'Ambrosio; Roger B Cohen; Sidrah Ahmad; Nicos Nicolaou; John A Ridge
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

Review 10.  Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.

Authors:  Olgun Elicin; Lluís Nisa; Alan Dal Pra; Beat Bojaxhiu; Marco Caversaccio; Michael Schmücking; Daniel M Aebersold; Roland Giger
Journal:  Radiother Oncol       Date:  2016-03-17       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.